Case Report
BibTex RIS Cite

Dalak ve Karaciğer Tutulumu ile Seyreden T Hücre/ Histiyositten Zengin B Hücreli Lenfoma Olgusu

Year 2017, Volume: 9 Issue: 4, 304 - 309, 01.12.2017

Abstract

T hücre/Histiyositten zengin B hücreli lenfoma (TC/HRBCL), diffüz büyük
B-hücreli lenfoma (DBBHL)’nin son zamanlarda tanınmış morfolojik bir
varyantıdır. DLBCL’lerin %2’den azını oluşturur. Diğer DLBCL alt tiplerine göre
daha erken yaşlarda görülür ve sıklıkla erkek bireyler etkilenir. Bu sunumda
diffüz karaciğer ve dalak tutulumu olan TC/HRBCL tanısı almış otuz üç yaşında
erkek bir olgunun klinik ve radyolojik bulgularının sunumu yapılmaktadır.

References

  • 1. Diffüz büyük B hücreli lenfoma tanı ve tedavi kılavuzu. 2016.
  • 2. Anderson T, Chabner BA, Young RC, et al. Malignant lymphoma. 1.The histology and staging of 473 patients at the National Cancer Institute. Cancer. 1982;50:2699-707.
  • 3. Ferhanoğlu B. Diffüz büyük B hücreli lenfomalar - klinik ve tedavi. Türk Hematoloji Derneği Klinisyen-Patolog Ortak Lenfoma Kursu. 2004; 54-62.
  • 4. Greer JP, Macon WR, Lamar RE, Wolff SN, Stein RS, et al. T-cell-rich large B-cell lymphomas: Diagnosis and response to therapy of 44 patients. J Clin Oncol. 1995;13: 1742-50.
  • 5. Abramson JS. T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis and management. The Oncologist. 2006;11:384-92.
  • 6. Jaffe ES.The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.Hematology Am Soc Hematol Educ Program. 2009:523-31.
  • 7. Ramsay AD, Smith WJ, Isaacson PG. T-cell rich B-cell lymphoma. Am J Surg Pathol. 1988;12:433-43.
  • 8. His ED, Hematopathology.1th ed.Philadelphıa, Churcil Livingstone, 2007:259-82.
  • 9. Schmidt U, Metz KA, Leder LD. T-cell-rich large B-cell lymphoma and lympocyte predominant Hodgkin’s disease: two closely related entities. Br J Haematol. 1995;90:398-403.
  • 10. McBride JA, Rodriguez J, Luthra R, et al. T-cell-rich B large cell lymphoma simulating lymphocyte-rich Hodgkin’s disease. Am J Surg Pathol. 1996;20:193-201.
  • 11. Ripp JA, Louie DC, Chan W, Nawaz H, Portlock CS. T-cell rich B-cell lymphoma: clinical distinctiveness and response to treatment in 45 patients. Leuk Lymphoma. 2002;43:1573-80.
  • 12. Weshi Amr E, Akhtar S, Mourad W A, Ajarım D, Abdelsalm M. T-cell/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: report on 61 patients and review of literature. Leukemia&Lymphoma. 2007;48:1764-73.

T-Cell/Histiocyte-Rich B-Cell Lymphoma with Spleen and Liver Involvement

Year 2017, Volume: 9 Issue: 4, 304 - 309, 01.12.2017

Abstract



T-Cell/Histiocyte-Rich B-Cell Lymphoma (TC/HRBCL) is a recently recognized
morphological variant of diffuse large B-cell lymphoma (DBBHL). It is compose
of less than 2% of DLBCLs. It is seen at earlier ages than other DLBCL subtypes
and is often affected by male subjects. In this presentation, we present
clinical and radiological findings of a thirty-three-year-old male patient with
a diagnosis of TC/HRBCL with diffuse liver and spleen involvement.






References

  • 1. Diffüz büyük B hücreli lenfoma tanı ve tedavi kılavuzu. 2016.
  • 2. Anderson T, Chabner BA, Young RC, et al. Malignant lymphoma. 1.The histology and staging of 473 patients at the National Cancer Institute. Cancer. 1982;50:2699-707.
  • 3. Ferhanoğlu B. Diffüz büyük B hücreli lenfomalar - klinik ve tedavi. Türk Hematoloji Derneği Klinisyen-Patolog Ortak Lenfoma Kursu. 2004; 54-62.
  • 4. Greer JP, Macon WR, Lamar RE, Wolff SN, Stein RS, et al. T-cell-rich large B-cell lymphomas: Diagnosis and response to therapy of 44 patients. J Clin Oncol. 1995;13: 1742-50.
  • 5. Abramson JS. T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis and management. The Oncologist. 2006;11:384-92.
  • 6. Jaffe ES.The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.Hematology Am Soc Hematol Educ Program. 2009:523-31.
  • 7. Ramsay AD, Smith WJ, Isaacson PG. T-cell rich B-cell lymphoma. Am J Surg Pathol. 1988;12:433-43.
  • 8. His ED, Hematopathology.1th ed.Philadelphıa, Churcil Livingstone, 2007:259-82.
  • 9. Schmidt U, Metz KA, Leder LD. T-cell-rich large B-cell lymphoma and lympocyte predominant Hodgkin’s disease: two closely related entities. Br J Haematol. 1995;90:398-403.
  • 10. McBride JA, Rodriguez J, Luthra R, et al. T-cell-rich B large cell lymphoma simulating lymphocyte-rich Hodgkin’s disease. Am J Surg Pathol. 1996;20:193-201.
  • 11. Ripp JA, Louie DC, Chan W, Nawaz H, Portlock CS. T-cell rich B-cell lymphoma: clinical distinctiveness and response to treatment in 45 patients. Leuk Lymphoma. 2002;43:1573-80.
  • 12. Weshi Amr E, Akhtar S, Mourad W A, Ajarım D, Abdelsalm M. T-cell/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: report on 61 patients and review of literature. Leukemia&Lymphoma. 2007;48:1764-73.
There are 12 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Case Report
Authors

Ayşe Kevser Demir

Ayşe Kefeli This is me

Ali Akın

Şafak Şahin This is me

Eda Albayrak This is me

Sedanur Kurban This is me

Memiş Hilmi Atay This is me

Publication Date December 1, 2017
Published in Issue Year 2017 Volume: 9 Issue: 4

Cite

APA Demir, A. K., Kefeli, A., Akın, A., Şahin, Ş., et al. (2017). Dalak ve Karaciğer Tutulumu ile Seyreden T Hücre/ Histiyositten Zengin B Hücreli Lenfoma Olgusu. Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi, 9(4), 304-309.
AMA Demir AK, Kefeli A, Akın A, Şahin Ş, Albayrak E, Kurban S, Atay MH. Dalak ve Karaciğer Tutulumu ile Seyreden T Hücre/ Histiyositten Zengin B Hücreli Lenfoma Olgusu. Gaziosmanpaşa Tıp Dergisi. December 2017;9(4):304-309.
Chicago Demir, Ayşe Kevser, Ayşe Kefeli, Ali Akın, Şafak Şahin, Eda Albayrak, Sedanur Kurban, and Memiş Hilmi Atay. “Dalak Ve Karaciğer Tutulumu Ile Seyreden T Hücre/ Histiyositten Zengin B Hücreli Lenfoma Olgusu”. Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi 9, no. 4 (December 2017): 304-9.
EndNote Demir AK, Kefeli A, Akın A, Şahin Ş, Albayrak E, Kurban S, Atay MH (December 1, 2017) Dalak ve Karaciğer Tutulumu ile Seyreden T Hücre/ Histiyositten Zengin B Hücreli Lenfoma Olgusu. Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi 9 4 304–309.
IEEE A. K. Demir, “Dalak ve Karaciğer Tutulumu ile Seyreden T Hücre/ Histiyositten Zengin B Hücreli Lenfoma Olgusu”, Gaziosmanpaşa Tıp Dergisi, vol. 9, no. 4, pp. 304–309, 2017.
ISNAD Demir, Ayşe Kevser et al. “Dalak Ve Karaciğer Tutulumu Ile Seyreden T Hücre/ Histiyositten Zengin B Hücreli Lenfoma Olgusu”. Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi 9/4 (December 2017), 304-309.
JAMA Demir AK, Kefeli A, Akın A, Şahin Ş, Albayrak E, Kurban S, Atay MH. Dalak ve Karaciğer Tutulumu ile Seyreden T Hücre/ Histiyositten Zengin B Hücreli Lenfoma Olgusu. Gaziosmanpaşa Tıp Dergisi. 2017;9:304–309.
MLA Demir, Ayşe Kevser et al. “Dalak Ve Karaciğer Tutulumu Ile Seyreden T Hücre/ Histiyositten Zengin B Hücreli Lenfoma Olgusu”. Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi, vol. 9, no. 4, 2017, pp. 304-9.
Vancouver Demir AK, Kefeli A, Akın A, Şahin Ş, Albayrak E, Kurban S, Atay MH. Dalak ve Karaciğer Tutulumu ile Seyreden T Hücre/ Histiyositten Zengin B Hücreli Lenfoma Olgusu. Gaziosmanpaşa Tıp Dergisi. 2017;9(4):304-9.

-